Cargando…
COVID-19—from mucosal immunology to IBD patients
Viral infections with SARS-CoV-2 can cause a multi-facetted disease, which is not only characterized by pneumonia and overwhelming systemic inflammatory immune responses, but which can also directly affect the digestive system and infect intestinal epithelial cells. Here, we review the current under...
Autores principales: | Weidinger, Carl, Hegazy, Ahmed Nabil, Glauben, Rainer, Siegmund, Britta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The authors. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893623/ https://www.ncbi.nlm.nih.gov/pubmed/33608656 http://dx.doi.org/10.1038/s41385-021-00384-9 |
Ejemplares similares
-
Metabolic Control of Epigenetics and Its Role in CD8(+) T Cell Differentiation and Function
por: Yerinde, Cansu, et al.
Publicado: (2019) -
Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells
por: Wu, Hao, et al.
Publicado: (2017) -
Targeting SOCE in Intestinal Epithelial Cells: A New Treatment Concept for Inflammatory Bowel Disease?
por: Glauben, Rainer, et al.
Publicado: (2022) -
Epithelial RAC1 niches in IBD: from barrier integrity to cytoskeletal plasticity
por: Haag, Lea-Maxie, et al.
Publicado: (2023) -
Deciphering the vedolizumab dosing conundrum in IBD: when less is more
por: Adolph, Timon Erik, et al.
Publicado: (2022)